(Q37894119)

24 August 2017

title

Patch testing in fixed drug eruptions--a 20-year review (English)

1 reference

24 August 2017

Ana Brinca

2

0 references

Margarida Gonçalo

object named as

Margarida Gonçalo

series ordinal

3

0 references

author name string

Pedro Andrade

series ordinal

1

1 reference

24 August 2017

publication date

27 June 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

65

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

195-201

1 reference

Fixed drug eruptions. Incidence, recognition, and avoidance

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Fixed drug eruption (FDE): changing scenario of incriminating drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Fixed drug eruption: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Drug patch testing in systemic cutaneous drug allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

The usefulness of skin tests to prove drug hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Fixed drug eruption: a prototypic disorder mediated by effector memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Nonpigmented fixed drug eruption induced by esomeprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Topical provocation in fixed drug eruption due to metamizol and naproxen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Patch testing in drug allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0536.2011.01946.X

10.1111/J.1600-0536.2011.01946.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference